Fresenius Medical Care AG (FMS) is the 137th largest of 300 Healthcare Services companies by market capitalisation, at 2.18 Bn, behind Establishment Labs Holdings Inc. at 2.18 Bn. It trades on a P/E of 0.07, 100% below the peer median of 23.82. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DVA | Davita Inc. | primary | H-14 | Healthcare Providers | HG-04 | 11.78 Bn | 10.12 | 0.84 | 11.09 Bn |
| 2 | RDNT | RadNet, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 5.81 Bn | 302.07 | 2.56 | 5.08 Bn |
| 3 | CON | Concentra Group Holdings Parent, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 4.32 Bn | 21.00 | 1.89 | 4.16 Bn |
| 4 | PRVA | Privia Health Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.60 Bn | 76.97 | 1.10 | 2.19 Bn |
| 5 | FMS | Fresenius Medical Care AG | primary | H-14 | Healthcare Providers | HG-04 | 2.18 Bn | 0.07 | 0.05 | 0.49 Bn |
| 6 | MD | Pediatrix Medical Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.14 Bn | 12.23 | 1.10 | 1.73 Bn |
| 7 | PGNY | Progyny, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.08 Bn | 26.44 | 1.59 | 1.84 Bn |
| 8 | SGRY | Surgery Partners, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 1.82 Bn | 22.26 | 0.54 | 1.61 Bn |
| 9 | USPH | U S Physical Therapy Inc /Nv | primary | H-14 | Healthcare Providers | HG-04 | 1.19 Bn | 23.82 | 1.46 | 1.16 Bn |
| 10 | STLN | Starling Oncology, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.61 Bn | -19.98 | 1.04 | 0.57 Bn |
| 11 | EVH | Evolent Health, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.48 Bn | -0.93 | 0.23 | 0.34 Bn |
| 12 | SRTA | Strata Critical Medical, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.46 Bn | 11.52 | 1.81 | 0.44 Bn |
| 13 | SBC | SBC Medical Group Holdings Inc | primary | H-14 | Healthcare Providers | HG-04 | 0.44 Bn | 11.66 | 2.51 | 0.26 Bn |
| 14 | INFU | InfuSystem Holdings, Inc | primary | H-14 | Healthcare Providers | HG-04 | 0.24 Bn | 28.58 | 1.70 | 0.24 Bn |
| 15 | AIRS | Airsculpt Technologies, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.18 Bn | -15.30 | 1.19 | 0.16 Bn |
| 16 | JYNT | JOINT Corp | primary | H-14 | Healthcare Providers | HG-04 | 0.12 Bn | 31.39 | 2.01 | 0.10 Bn |
| 17 | RYOJ | rYojbaba Co., Ltd. | primary | H-14 | Healthcare Providers | HG-04 | 0.05 Bn | -47.64 | 6.80 | 0.05 Bn |
| 18 | BTMD | biote Corp. | primary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | 6.80 | 0.24 | 0.03 Bn |
| 19 | DCGO | DocGo Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | -0.19 | 0.14 | 0.01 Bn |
| 20 | PIII | P3 Health Partners Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.03 Bn | -0.12 | 0.02 | 0.01 Bn |
| 21 | EUDA | EUDA Health Holdings Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.03 Bn | -9.19 | 3.78 | 0.03 Bn |
| 22 | SY | So-Young International Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -0.59 | 0.09 | -0.09 Bn |
| 23 | LDDD | Longduoduo Co Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -35.14 | 7.18 | 0.01 Bn |
| 24 | AMS | American Shared Hospital Services | primary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | -3.76 | 0.33 | 0.00 Bn |
| 25 | BMGL | Basel Medical Group Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | 20.47 | — | 0.01 Bn |
| 26 | LFST | LifeStance Health Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.09 | 0.00 | -0.22 Bn |
| 27 | CDIX | Cardiff Lexington Corp | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -1.10 | — | 0.01 Bn |
| 28 | IVF | INVO Fertility, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.49 | 0.45 | 0.00 Bn |
| 29 | FCHS | First Choice Healthcare Solutions, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.04 | — | 0.00 Bn |
| 30 | NIVF | NewGenIvf Group Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.00 | 0.00 | 0.00 Bn |
| 31 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 670.47 Bn | 31.87 | 6.85 | 649.71 Bn |
| 32 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 461.14 Bn | 73.01 | 7.16 | 454.57 Bn |
| 33 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 376.50 Bn | 118.81 | 5.66 | 369.36 Bn |
| 34 | UNH | Unitedhealth Group Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 361.56 Bn | 24.25 | 0.80 | 330.09 Bn |
| 35 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 316.37 Bn | 3.61 | 7.46 | 308.68 Bn |
| 36 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 189.35 Bn | 34.90 | 4.06 | 183.75 Bn |
| 37 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 187.96 Bn | -64.93 | 6.17 | 184.78 Bn |
| 38 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 164.13 Bn | 37.58 | 2.58 | 152.43 Bn |
| 39 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 141.52 Bn | 32.12 | 11.24 | 133.66 Bn |
| 40 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 130.93 Bn | 41.46 | 11.87 | 125.71 Bn |
| 41 | CVS | CVS HEALTH Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 124.22 Bn | 25.43 | 0.30 | 110.26 Bn |
| 42 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 119.05 Bn | 24.61 | 3.27 | 109.83 Bn |
| 43 | HCA | HCA Healthcare, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 90.36 Bn | 11.53 | 1.16 | 89.35 Bn |
| 44 | ELV | Elevance Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 90.04 Bn | 18.20 | 0.45 | 54.09 Bn |
| 45 | CI | Cigna Group | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 75.04 Bn | 10.91 | 0.27 | 67.78 Bn |
| 46 | BSX | Boston Scientific Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 68.98 Bn | 18.77 | 3.29 | 68.44 Bn |
| 47 | TEL | TE Connectivity plc | secondary | I-07 | Machinery | IG-02 | 60.75 Bn | 19.68 | 3.14 | 59.51 Bn |
| 48 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 54.15 Bn | 11.62 | 1.01 | 46.77 Bn |
| 49 | AME | Ametek Inc/ | secondary | I-04 | Machinery | IG-02 | 53.57 Bn | 33.99 | 6.81 | 53.08 Bn |
| 50 | EW | Edwards Lifesciences Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 51.82 Bn | 51.63 | 7.96 | 47.57 Bn |
| 51 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 51.56 Bn | 54.73 | 2.22 | 50.69 Bn |
| 52 | HUM | Humana Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 48.73 Bn | 35.52 | 0.33 | 24.86 Bn |
| 53 | SLF | Sun Life Financial Inc | secondary | F-12 | Insurance | FG-04 | 45.45 Bn | 19.26 | — | 44.28 Bn |
| 54 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.41 Bn | -25.11 | — | 44.41 Bn |
| 55 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.66 Bn | 61.30 | 2.46 | 39.01 Bn |
| 56 | ONC | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 40.45 Bn | 61.68 | 6.60 | 35.35 Bn |
| 57 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 35.56 Bn | 0.81 | 3.31 | 34.21 Bn |
| 58 | DXCM | Dexcom Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 34.29 Bn | 34.30 | 6.90 | 32.34 Bn |
| 59 | CNC | Centene Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 33.57 Bn | -6.58 | 0.17 | 6.52 Bn |
| 60 | RMD | Resmed Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.32 Bn | 21.88 | 5.89 | 31.85 Bn |
| 61 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 31.58 Bn | 15.40 | 1.48 | 29.47 Bn |
| 62 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.55 Bn | -31.47 | 24.22 | 26.39 Bn |
| 63 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.65 Bn | 15.91 | 4.41 | 21.11 Bn |
| 64 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 24.76 Bn | -20.46 | 2,266.99 | 24.76 Bn |
| 65 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 24.25 Bn | 44.14 | 7.29 | 23.81 Bn |
| 66 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 22.18 Bn | 27.45 | 3.67 | 21.70 Bn |
| 67 | THC | Tenet Healthcare Corp | secondary | H-13 | Healthcare Providers | HG-04 | 22.02 Bn | 9.82 | 1.01 | 19.85 Bn |
| 68 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 20.87 Bn | 15.92 | 6.62 | 18.21 Bn |
| 69 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.72 Bn | -48.01 | 1.34 | 18.83 Bn |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 19.00 Bn | 22.43 | 2.23 | 18.59 Bn |
| 71 | NDSN | Nordson Corp | secondary | I-04 | Machinery | IG-02 | 17.69 Bn | 31.87 | 5.94 | 17.58 Bn |
| 72 | FTV | Fortive Corp | secondary | I-04 | Machinery | IG-02 | 17.51 Bn | 32.77 | 4.06 | 17.14 Bn |
| 73 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.68 Bn | 11.95 | 0.95 | 15.93 Bn |
| 74 | IEX | Idex Corp /De/ | secondary | I-10 | Machinery | IG-02 | 16.51 Bn | 31.80 | 4.61 | 15.89 Bn |
| 75 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.98 Bn | 22.65 | 4.74 | 15.59 Bn |
| 76 | SOLV | Solventum Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 15.96 Bn | 11.12 | 1.92 | 15.55 Bn |
| 77 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.65 Bn | 16.63 | 3.40 | 14.03 Bn |
| 78 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.81 Bn | 17.21 | 6.08 | 13.97 Bn |
| 79 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.70 Bn | 41.27 | 4.18 | 14.09 Bn |
| 80 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 13.77 Bn | 58.39 | 3.25 | 13.63 Bn |
| 81 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 13.19 Bn | 573.65 | 1.19 | 11.04 Bn |
| 82 | HALO | Halozyme Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.99 Bn | 31.41 | 7.81 | 12.76 Bn |
| 83 | PEN | Penumbra Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 12.65 Bn | 78.78 | 8.40 | 11.99 Bn |
| 84 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.88 Bn | 219.20 | 14.30 | 11.57 Bn |
| 85 | MOG-A | Moog Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 11.70 Bn | 31.04 | 2.71 | 11.64 Bn |
| 86 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.50 Bn | -38.39 | 109.55 | 10.81 Bn |
| 87 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.79 Bn | -70.21 | 18.42 | 10.47 Bn |
| 88 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.58 Bn | -67.19 | 17.27 | 10.47 Bn |
| 89 | GMED | Globus Medical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.56 Bn | 19.71 | 3.36 | 9.96 Bn |
| 90 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.44 Bn | 27.81 | 3.42 | 9.90 Bn |
| 91 | MOH | Molina Healthcare, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 10.36 Bn | -1,479.42 | 0.23 | 1.44 Bn |
| 92 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.33 Bn | -27.08 | — | 9.57 Bn |
| 93 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.29 Bn | -54.70 | — | 10.29 Bn |
| 94 | UHS | Universal Health Services Inc | secondary | H-13 | Healthcare Providers | HG-04 | 10.09 Bn | 6.61 | 0.56 | 9.95 Bn |
| 95 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.76 Bn | -13.31 | 144.25 | 8.60 Bn |
| 96 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 97 | OSCR | Oscar Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 9.70 Bn | 17.60 | 0.63 | 1.14 Bn |
| 98 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 99 | ATR | Aptargroup, Inc. | secondary | I-04 | Machinery | IG-02 | 8.17 Bn | 22.51 | 2.08 | 7.97 Bn |
| 100 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.84 Bn | 118.50 | 4.70 | 7.18 Bn |
| 101 | HNGE | Hinge Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 7.20 Bn | 67.06 | 10.00 | 6.81 Bn |
| 102 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.66 Bn | -743.22 | 4,781.78 | 6.66 Bn |
| 103 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.49 Bn | -39.83 | 1.22 | 6.11 Bn |
| 104 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.22 Bn | -143.08 | -415.80 | 6.22 Bn |
| 105 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.10 Bn | -12.93 | 2.01 | 5.81 Bn |
| 106 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.10 Bn | 44.00 | 13.52 | 5.81 Bn |
| 107 | TFX | Teleflex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.09 Bn | -5.40 | 2.70 | 5.79 Bn |
| 108 | NOVT | Novanta Inc | secondary | I-04 | Machinery | IG-02 | 6.04 Bn | 114.08 | 5.86 | 5.32 Bn |
| 109 | DBVT | DBV Technologies S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.98 Bn | -33.97 | 1,191.16 | 5.80 Bn |
| 110 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.74 Bn | -0.12 | — | 5.74 Bn |
| 111 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.72 Bn | 26.56 | 1.83 | 5.59 Bn |
| 112 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.71 Bn | -210.49 | 30.66 | 5.39 Bn |
| 113 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 5.62 Bn | 22.02 | 3.93 | 5.51 Bn |
| 114 | MMSI | Merit Medical Systems Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.29 Bn | 36.36 | 3.35 | 4.84 Bn |
| 115 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.06 Bn | -17.61 | — | 5.06 Bn |
| 116 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.78 Bn | 12.57 | 4.20 | 3.83 Bn |
| 117 | HAE | Haemonetics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.66 Bn | 48.37 | 3.44 | 4.43 Bn |
| 118 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.51 Bn | -22.88 | — | 4.51 Bn |
| 119 | LIVN | LivaNova PLC | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.46 Bn | 23.53 | 3.03 | 3.94 Bn |
| 120 | ITGR | Integer Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.27 Bn | 33.25 | 2.32 | 4.25 Bn |
| 121 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.27 Bn | -8.34 | 1,183.97 | 4.27 Bn |
| 122 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.19 Bn | -11.85 | — | 4.19 Bn |
| 123 | ICUI | Icu Medical Inc/De | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.16 Bn | 124.57 | 1.93 | 3.86 Bn |
| 124 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.14 Bn | 11.67 | 3.11 | 3.92 Bn |
| 125 | IRTC | iRhythm Holdings, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 4.05 Bn | -290.62 | 4.91 | 3.46 Bn |
| 126 | TLX | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.97 Bn | — | — | 3.71 Bn |
| 127 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.96 Bn | -55.30 | — | 3.96 Bn |
| 128 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.95 Bn | -46.92 | — | 3.95 Bn |
| 129 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 130 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.79 Bn | -8.23 | 32.36 | 3.08 Bn |
| 131 | PLSE | Pulse Biosciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.78 Bn | -46.93 | 4,827.23 | 3.78 Bn |
| 132 | OPCH | Option Care Health, Inc. | secondary | H-15 | Healthcare Providers | HG-04 | 3.74 Bn | 17.87 | 0.66 | 3.55 Bn |
| 133 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | 17.31 | 0.59 | 2.49 Bn |
| 134 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | -77.06 | 5.97 | 3.17 Bn |
| 135 | CRVL | Corvel Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 3.52 Bn | 44.38 | — | 3.17 Bn |
| 136 | IPGP | Ipg Photonics Corp | secondary | I-04 | Machinery | IG-02 | 3.25 Bn | 117.88 | 3.04 | 2.38 Bn |
| 137 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.18 Bn | -12.25 | 446.55 | 3.18 Bn |
| 138 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.07 Bn | -11.35 | 593.06 | 2.55 Bn |
| 139 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.01 Bn | -16.01 | 6.70 | 2.31 Bn |
| 140 | TMDX | TransMedics Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.01 Bn | 17.57 | 4.50 | 2.54 Bn |
| 141 | WRBY | Warby Parker Inc. | secondary | D-10 | Apparel and Luxury | DG-04 | 2.89 Bn | 373.63 | 3.17 | 2.60 Bn |
| 142 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.81 Bn | -8.24 | 76.53 | 2.37 Bn |
| 143 | ALHC | Alignment Healthcare, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.80 Bn | 68.79 | 0.61 | 2.10 Bn |
| 144 | CHRN | ChronoScale Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.80 Bn | -236.06 | 35.81 | 2.79 Bn |
| 145 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.68 Bn | 1.17 | 0.06 | -3.12 Bn |
| 146 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.67 Bn | -63.19 | — | 2.67 Bn |
| 147 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.60 Bn | -80.02 | — | 2.60 Bn |
| 148 | ACHC | Acadia Healthcare Company, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 2.57 Bn | -2.95 | 0.76 | 2.40 Bn |
| 149 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.56 Bn | -6.66 | 4.79 | 2.21 Bn |
| 150 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.55 Bn | -23.71 | 3.24 | 2.18 Bn |
| 151 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.54 Bn | -2.33 | 0.23 | 0.71 Bn |
| 152 | ATRC | AtriCure, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.54 Bn | 240.71 | 4.46 | 2.37 Bn |
| 153 | AXGN | Axogen, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.51 Bn | -169.72 | 10.00 | 2.40 Bn |
| 154 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.49 Bn | -21.05 | 1.91 | 2.40 Bn |
| 155 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.43 Bn | 13.63 | 2.53 | 1.63 Bn |
| 156 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.40 Bn | -6.86 | — | 2.40 Bn |
| 157 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.39 Bn | -4.08 | — | 2.12 Bn |
| 158 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.35 Bn | -21.69 | 13.81 | 2.35 Bn |
| 159 | CLOV | Clover Health Investments, Corp. /De | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.23 Bn | -121.48 | 0.90 | 1.99 Bn |
| 160 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.23 Bn | -42.08 | — | 1.92 Bn |
| 161 | UFPT | Ufp Technologies Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.22 Bn | 30.67 | 3.51 | 2.21 Bn |
| 162 | ESTA | Establishment Labs Holdings Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.18 Bn | -56.10 | 8.88 | 2.11 Bn |
| 163 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 6.68 | 6.73 | 1.65 Bn |
| 164 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.07 Bn | -4.99 | 2,074.50 | 2.07 Bn |
| 165 | VCEL | Vericel Corp | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.07 Bn | 82.38 | 6.75 | 1.90 Bn |
| 166 | NVCR | NovoCure Ltd | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.05 Bn | -13.79 | 2.93 | 1.61 Bn |
| 167 | ASTH | Astrana Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.85 Bn | 52.91 | 0.48 | 1.45 Bn |
| 168 | LMAT | Lemaitre Vascular Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.84 Bn | 28.03 | 7.01 | 1.46 Bn |
| 169 | INSP | Inspire Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.79 Bn | 13.24 | 1.99 | 1.47 Bn |
| 170 | BLFS | Biolife Solutions Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.73 Bn | 29.94 | 16.87 | 1.65 Bn |
| 171 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.66 Bn | 173.74 | 16.55 | 1.63 Bn |
| 172 | OMCL | Omnicell, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.60 Bn | 40.90 | 1.28 | 1.31 Bn |
| 173 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.57 Bn | 7.98 | 3.74 | 0.99 Bn |
| 174 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | -9.11 | -0.10 | 1.27 Bn |
| 175 | ARDT | Ardent Health, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.53 Bn | 9.07 | 0.24 | 0.80 Bn |
| 176 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.52 Bn | 14.11 | 1.56 | 1.16 Bn |
| 177 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -3.26 | 2.10 | 1.21 Bn |
| 178 | HCSG | Healthcare Services Group Inc | secondary | I-27 | Business Services | IG-06 | 1.49 Bn | 12.13 | 0.80 | 1.33 Bn |
| 179 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | -86.49 | 4.43 | 1.36 Bn |
| 180 | CNMD | CONMED Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.48 Bn | 26.23 | 1.08 | 1.44 Bn |
| 181 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | -9.03 | — | 1.48 Bn |
| 182 | ATEC | Alphatec Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.46 Bn | -13.30 | 1.79 | 1.34 Bn |
| 183 | INNV | InnovAge Holding Corp. | secondary | H-15 | Healthcare Providers | HG-04 | 1.46 Bn | -93.86 | 1.54 | 1.32 Bn |
| 184 | AGL | agilon health, inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.45 Bn | -6.23 | 0.24 | 1.26 Bn |
| 185 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -23.64 | — | 1.43 Bn |
| 186 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -42.65 | 5.18 | 1.34 Bn |
| 187 | TNDM | Tandem Diabetes Care Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.41 Bn | -22.23 | 1.35 | 0.95 Bn |
| 188 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.68 | 35.84 | 1.38 Bn |
| 189 | KMTS | Kestra Medical Technologies, Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.37 Bn | -10.39 | 14.37 | 1.01 Bn |
| 190 | NUTX | Nutex Health Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.36 Bn | 4.98 | 1.60 | 1.15 Bn |
| 191 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.35 Bn | -33.54 | — | 1.13 Bn |
| 192 | EYE | National Vision Holdings, Inc. | secondary | D-36 | Retail | DG-10 | 1.34 Bn | 48.14 | 0.68 | 1.30 Bn |
| 193 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.27 Bn | -175.12 | 0.77 | 0.99 Bn |
| 194 | AORT | Artivion, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.24 Bn | -392.93 | 2.64 | 1.17 Bn |
| 195 | MNKD | Mannkind Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -28.25 | 3.13 | 1.12 Bn |
| 196 | THRM | Gentherm Inc | secondary | I-04 | Machinery | IG-02 | 1.22 Bn | 11.31 | 0.78 | 1.01 Bn |
| 197 | PRCT | PROCEPT BioRobotics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.21 Bn | -10.60 | 3.60 | 0.94 Bn |
| 198 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.21 Bn | -31.89 | 2.06 | 0.91 Bn |
| 199 | UTI | Universal Technical Institute Inc | secondary | D-28 | Consumer Services | DG-09 | 1.19 Bn | 34.68 | 1.35 | 1.02 Bn |
| 200 | STAA | Staar Surgical Co | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.19 Bn | 61.43 | 3.49 | 1.00 Bn |
| 201 | DRTS | Alpha Tau Medical Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.18 Bn | 12.76 | — | 1.08 Bn |
| 202 | AVNS | Avanos Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | -15.62 | 1.63 | 1.10 Bn |
| 203 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.16 Bn | -4.89 | 15.08 | 1.16 Bn |
| 204 | IXHL | Incannex Healthcare Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.13 Bn | -23.39 | — | 1.13 Bn |
| 205 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.12 Bn | -5.47 | — | 1.12 Bn |
| 206 | IRMD | Iradimed Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.11 Bn | 48.23 | 12.84 | 1.05 Bn |
| 207 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.05 Bn | 71.82 | 1.41 | 0.80 Bn |
| 208 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | -90.39 | — | 0.96 Bn |
| 209 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.99 Bn | -15.69 | 23.80 | 0.80 Bn |
| 210 | BVS | Bioventus Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.98 Bn | 15.88 | 1.68 | 0.95 Bn |
| 211 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -34.03 | — | 0.97 Bn |
| 212 | INMD | InMode Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.96 Bn | 11.16 | 2.56 | 0.48 Bn |
| 213 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -11.60 | — | 0.73 Bn |
| 214 | IVA | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.91 Bn | 106.75 | 176.63 | 0.91 Bn |
| 215 | BBNX | Beta Bionics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.89 Bn | -12.14 | 7.45 | 0.71 Bn |
| 216 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.85 Bn | -10.22 | 378.81 | 0.85 Bn |
| 217 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.85 Bn | -10.66 | 103.24 | 0.85 Bn |
| 218 | SIBN | SI-BONE, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.83 Bn | -56.79 | 3.88 | 0.68 Bn |
| 219 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.93 | 9.13 | 0.66 Bn |
| 220 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.77 Bn | 16.09 | 0.95 | 0.62 Bn |
| 221 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.76 Bn | -7.69 | 3.15 | 0.57 Bn |
| 222 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | 12.72 | 5.44 | 0.52 Bn |
| 223 | WOOF | Petco Health & Wellness Company, Inc. | secondary | S-13 | Staples Retail | SG-06 | 0.71 Bn | 606.69 | 0.12 | 0.55 Bn |
| 224 | SSII | SS Innovations International, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.68 Bn | -44.18 | 12.93 | 0.66 Bn |
| 225 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.67 Bn | -8.52 | 63.63 | 0.67 Bn |
| 226 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.66 Bn | 5.28 | 1.77 | 0.41 Bn |
| 227 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.65 Bn | -35.37 | 5.47 | 0.60 Bn |
| 228 | ANGO | Angiodynamics Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.64 Bn | -17.47 | 2.01 | 0.59 Bn |
| 229 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -361,802.81 | — | 0.35 Bn |
| 230 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -2.97 | — | 0.60 Bn |
| 231 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -17.33 | 1.88 | 0.55 Bn |
| 232 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.59 Bn | 1,193.73 | 6.18 | 0.49 Bn |
| 233 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -18.87 | — | 0.57 Bn |
| 234 | SENS | Senseonics Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.57 Bn | -5.22 | 11.76 | 0.33 Bn |
| 235 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -2.54 | 5.80 | 0.42 Bn |
| 236 | BWAY | Brainsway Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.55 Bn | 58.13 | 9.10 | 0.49 Bn |
| 237 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -15.97 | 348.01 | 0.43 Bn |
| 238 | KIDS | Orthopediatrics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.54 Bn | -13.66 | 2.15 | 0.50 Bn |
| 239 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -7.68 | 23.08 | 0.24 Bn |
| 240 | CERS | Cerus Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.52 Bn | 9.70 | 2.07 | 0.46 Bn |
| 241 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -5.34 | 33.78 | 0.32 Bn |
| 242 | NPCE | NeuroPace Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.51 Bn | -26.60 | 5.11 | 0.45 Bn |
| 243 | TCMD | Tactile Systems Technology Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.50 Bn | 20.16 | 1.43 | 0.41 Bn |
| 244 | DDD | 3D Systems Corp | secondary | I-12 | Machinery | IG-02 | 0.49 Bn | -9.74 | 1.27 | 0.36 Bn |
| 245 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -80.05 | 610.85 | 0.34 Bn |
| 246 | SGHT | Sight Sciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.46 Bn | -21.07 | 5.48 | 0.38 Bn |
| 247 | MCTA | Charming Medical Ltd | secondary | D-29 | Consumer Services | DG-09 | 0.45 Bn | -42,242.59 | 92.66 | 0.44 Bn |
| 248 | IKT | Inhibikase Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -6.71 | — | 0.28 Bn |
| 249 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -4.48 | 44.22 | 0.35 Bn |
| 250 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -4.57 | 43.22 | 0.23 Bn |
| 251 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -12.19 | 860.32 | 0.30 Bn |
| 252 | CLPT | ClearPoint Neuro, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -14.56 | 10.03 | 0.39 Bn |
| 253 | SI | Shoulder Innovations, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -12.04 | 7.02 | 0.32 Bn |
| 254 | CARL | Carlsmed, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -11.60 | 6.66 | 0.31 Bn |
| 255 | MTLS | Materialise Nv | secondary | T-20 | Business Applications | TG-03 | 0.42 Bn | 32.22 | 1.31 | 0.26 Bn |
| 256 | VTVT | vTv Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -87.30 | 11.27 | 0.42 Bn |
| 257 | AUNA | Auna S.A. | secondary | H-13 | Healthcare Providers | HG-04 | 0.40 Bn | 12.92 | 0.09 | 0.24 Bn |
| 258 | CYH | Community Health Systems Inc | secondary | H-13 | Healthcare Providers | HG-04 | 0.39 Bn | 2.36 | 0.03 | 0.24 Bn |
| 259 | OFIX | Orthofix Medical Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.38 Bn | -8.71 | 0.46 | 0.28 Bn |
| 260 | ACHV | Achieve Life Sciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.36 Bn | — | — | 0.36 Bn |
| 261 | RCEL | AVITA Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.34 Bn | -10.49 | 2.26 | 0.33 Bn |
| 262 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.33 Bn | 3.81 | 0.33 | 0.12 Bn |
| 263 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -5.53 | — | 0.32 Bn |
| 264 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.81 | 0.42 | 0.18 Bn |
| 265 | VNDA | Vanda Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.17 | 1.49 | 0.15 Bn |
| 266 | TMCI | Treace Medical Concepts, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.32 Bn | -5.54 | 1.55 | 0.27 Bn |
| 267 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -332.50 | 7.43 | 0.27 Bn |
| 268 | SION | Sionna Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -3.11 | — | 0.30 Bn |
| 269 | TTRX | Turn Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -39.28 | — | 0.30 Bn |
| 270 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | 0.03 | 0.01 | -10.76 Bn |
| 271 | OBIO | Orchestra BioMed Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | -5.07 | 9.44 | 0.11 Bn |
| 272 | SMTI | Sanara MedTech Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | -9.75 | 2.10 | 0.30 Bn |
| 273 | TBI | TrueBlue, Inc. | secondary | I-25 | Business Services | IG-06 | 0.30 Bn | -5.30 | 0.18 | 0.28 Bn |
| 274 | CV | CapsoVision, Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | -10.76 | 20.48 | 0.29 Bn |
| 275 | FULC | Fulcrum Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.29 | — | 0.29 Bn |
| 276 | ZNTL | Zentalis Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -2.09 | — | 0.29 Bn |
| 277 | TLSI | TriSalus Life Sciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.29 Bn | -4.91 | 6.40 | 0.24 Bn |
| 278 | ANIK | Anika Therapeutics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | -131.92 | 2.33 | 0.24 Bn |
| 279 | RXST | RxSight, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.27 Bn | -7.02 | 2.13 | -0.13 Bn |
| 280 | AKBA | Akebia Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.89 | 1.20 | 0.11 Bn |
| 281 | AHG | Akso Health Group | secondary | H-16 | Healthcare Providers | HG-04 | 0.25 Bn | — | — | 0.25 Bn |
| 282 | PROF | Profound Medical Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.25 Bn | 3.72 | 12.97 | 0.21 Bn |
| 283 | SIGA | Siga Technologies Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 8.05 | — | 0.08 Bn |
| 284 | ELMD | Electromed, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.23 Bn | 20.14 | 3.09 | 0.21 Bn |
| 285 | UTMD | Utah Medical Products Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 22.78 | 6.23 | 0.14 Bn |
| 286 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.14 | — | 0.22 Bn |
| 287 | TNXP | Tonix Pharmaceuticals Holding Corp. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.39 | 7.64 | 0.22 Bn |
| 288 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -59.56 | 3.19 | 0.19 Bn |
| 289 | NERV | Minerva Neurosciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -33.13 | — | 0.22 Bn |
| 290 | ORGO | Organogenesis Holdings Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.21 Bn | -2.11 | 0.46 | 0.16 Bn |
| 291 | ACOG | Alpha Cognition Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.30 | 14.98 | 0.16 Bn |
| 292 | STIM | Neuronetics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.20 Bn | -6.27 | 1.28 | 0.18 Bn |
| 293 | PDEX | Pro Dex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.20 Bn | 16.54 | 2.66 | 0.19 Bn |
| 294 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -18.70 | 109.24 | 0.15 Bn |
| 295 | HSDT | Solana Co | secondary | F-22 | Capital Markets | FG-05 | 0.19 Bn | -1.20 | 15.69 | 0.19 Bn |
| 296 | MCUJF | Medicure Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -36.84 | 8.05 | 0.19 Bn |
| 297 | CRDL | Cardiol Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -9.37 | — | 0.17 Bn |
| 298 | LONA | LeonaBio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.50 | — | 0.13 Bn |
| 299 | LENZ | LENZ Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.40 | 24.57 | 0.18 Bn |
| 300 | NNBR | Nn Inc | secondary | I-09 | Machinery | IG-02 | 0.17 Bn | -4.67 | 0.38 | 0.16 Bn |